Sonidegib for the treatment of advanced basal cell carcinoma in a liver transplant recipient

J Dermatol. 2023 Oct;50(10):e323-e324. doi: 10.1111/1346-8138.16818. Epub 2023 May 8.

Authors

Alfredo Piccerillo^{1

2}, Simone Cappilli^{1

2}, Alessio Costantini^{1

2}, Ketty Peris^{1

2}, Alessandro Di Stefani^{1

2}

Affiliations

¹ Dipartimento di Scienze Mediche e Chirurgiche Addominali ed Endrocrino Metaboliche, UOC di Dermatologia, Fondazione Policlinico Universitario A. Gemelli - IRCCS, Rome, Italy.
² Dermatologia, Università Cattolica del Sacro Cuore, Rome, Italy.

PMID: 37157871
DOI: 10.1111/1346-8138.16818

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Agents* / therapeutic use
Biphenyl Compounds / therapeutic use
Carcinoma, Basal Cell* / drug therapy
Carcinoma, Basal Cell* / pathology
Carcinoma, Basal Cell* / surgery
Humans
Liver Transplantation* / adverse effects
Skin Neoplasms* / diagnosis
Skin Neoplasms* / drug therapy
Skin Neoplasms* / surgery

Substances

sonidegib
Biphenyl Compounds
Antineoplastic Agents